These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 29870728)

  • 1. Funding needed for cure research to eliminate hepatitis B.
    Brownstein A; Cohen C
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):149. PubMed ID: 29870728
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).
    Revill P; Locarnini S
    Curr Opin Pharmacol; 2016 Oct; 30():144-150. PubMed ID: 27639371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic agents for chronic hepatitis B.
    Brahmania M; Feld J; Arif A; Janssen HL
    Lancet Infect Dis; 2016 Feb; 16(2):e10-21. PubMed ID: 26795693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel viral and host targets to cure hepatitis B.
    Ko C; Michler T; Protzer U
    Curr Opin Virol; 2017 Jun; 24():38-45. PubMed ID: 28433762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis B: Are we close to a cure?
    Loggi E; Vitale G; Conti F; Bernardi M; Andreone P
    Dig Liver Dis; 2015 Oct; 47(10):836-41. PubMed ID: 26138799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus reactivation after direct-acting antivirals for chronic hepatitis C infection.
    Thibault V
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):145-147. PubMed ID: 29371018
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: hepatitis B reactivation in patients with chronic hepatitis C during direct-acting antiviral therapy-authors' reply.
    Londoño MC; Carrión JA; Forns X
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1559-1560. PubMed ID: 28503869
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent progress in the treatment of chronic hepatitis B].
    Yokosuka O
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(1):10-18. PubMed ID: 29353845
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver diseases. Hepatitis B].
    Rizo Robles MT
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():184-6. PubMed ID: 20959245
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B virus infection--natural history and clinical consequences.
    Ganem D; Prince AM
    N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
    [No Abstract]   [Full Text] [Related]  

  • 11. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status and future directions of hepatitis B antiviral drug discovery.
    Tang L; Zhao Q; Wu S; Cheng J; Chang J; Guo JT
    Expert Opin Drug Discov; 2017 Jan; 12(1):5-15. PubMed ID: 27797587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review.
    Baugh SDP
    Infect Disord Drug Targets; 2017; 17(1):24-35. PubMed ID: 28056752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hepatitis B-free generation in China: from dream to reality.
    Fan R; Yin X; Liu Z; Liu Z; Lau G; Hou J
    Lancet Infect Dis; 2016 Oct; 16(10):1103-1105. PubMed ID: 27676339
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monitoring and treatment strategy for chronic hepatitis B and antiviral resistant hepatitis B].
    Kim TY; Sohn JH
    Korean J Gastroenterol; 2007 Jun; 49(6):346-55. PubMed ID: 17641552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B vaccines: protective efficacy and therapeutic potential.
    Michel ML; Tiollais P
    Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.
    Zoulim F
    J Hepatol; 2005 Mar; 42(3):302-8. PubMed ID: 15710212
    [No Abstract]   [Full Text] [Related]  

  • 18. Does antiplatelet therapy really reduce the risk of hepatocellular carcinoma in hepatitis B patients with antiviral drugs?
    Lo GH
    Hepatology; 2018 Apr; 67(4):1642-1643. PubMed ID: 29356042
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic hepatitis B: A wave of new therapies on the horizon.
    Block TM; Rawat S; Brosgart CL
    Antiviral Res; 2015 Sep; 121():69-81. PubMed ID: 26112647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus: new therapeutic perspectives.
    Lin CL; Yang HC; Kao JH
    Liver Int; 2016 Jan; 36 Suppl 1():85-92. PubMed ID: 26725903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.